AAAAAA
Results:
1-8
|
Results: 8
Authors:
Fielding, RM
Citation: Rm. Fielding, Relationship of pharmacokinetically-calculated volumes of distribution to the physiologic distribution of liposomal drugs in tissues: Implications for the characterization of liposomal formulations, PHARM RES, 18(2), 2001, pp. 238-242
Authors:
Bekersky, I
Fielding, RM
Dressler, DE
Kline, S
Buell, DN
Walsh, TJ
Citation: I. Bekersky et al., Pharmacokinetics, excretion, and mass balance of C-14 after administrationof C-14-cholesterol-labeled AmBisome to healthy volunteers, J CLIN PHAR, 41(9), 2001, pp. 963-971
Authors:
Bekersky, I
Boswell, GW
Hiles, R
Fielding, RM
Buell, D
Walsh, TJ
Citation: I. Bekersky et al., Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome (R)): A 91-day study in rats, PHARM RES, 17(12), 2000, pp. 1494-1502
Authors:
Bekersky, I
Fielding, RM
Buell, D
Lawrence, I
Citation: I. Bekersky et al., Lipid-based amphotericin B formulations: from animals to man, PHARM SCI T, 2(6), 1999, pp. 230-236
Authors:
Fielding, RM
Lasic, DD
Citation: Rm. Fielding et Dd. Lasic, Liposomes in the treatment of infectious diseases, EXPERT OP T, 9(12), 1999, pp. 1679-1688
Authors:
Fielding, RM
Moon-McDermott, L
Lewis, RO
Citation: Rm. Fielding et al., Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administration, J DRUG TAR, 6(6), 1999, pp. 415-426
Authors:
Bekersky, I
Boswell, GW
Hiles, R
Fielding, RM
Buell, D
Walsh, TJ
Citation: I. Bekersky et al., Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome (R)) in beagle dogs, PHARM RES, 16(11), 1999, pp. 1694-1701
Authors:
Fielding, RM
Moon-Mcdermott, L
Lewis, RO
Horner, MJ
Citation: Rm. Fielding et al., Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey, ANTIM AG CH, 43(3), 1999, pp. 503-509
Risultati:
1-8
|